Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Feb 18;9(2):e88639.
doi: 10.1371/journal.pone.0088639. eCollection 2014.

Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide

Affiliations
Clinical Trial

Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide

Rajeshwary Ghosh et al. PLoS One. .

Abstract

Introduction: Excessive aggregation of platelets at the site of plaque rupture on the coronary artery led to the formation of thrombus which is reported to precipitate acute myocardial infarction (AMI). Nitric oxide (NO) has been reported to inhibit platelet aggregation and induce thrombolysis through the in situ formation of plasmin. As the plasma NO level in AMI patients from two different ethnic groups was reduced to 0 µM (median) compared to 4.0 µM (median) in normal controls, the effect of restoration of the NO level to normal ranges on the rate of death due to AMI was determined.

Methods and results: The restoration of plasma NO level was achieved by a sticking small cotton pad (10×25 mm) containing 0.28 mmol sodium nitroprusside (SNP) in 0.9% NaCl to the abdominal skin of the participants using non-toxic adhesive tape which was reported to normalize the plasma NO level. The participants (8,283) were volunteers in an independent study who had different kinds of cancers and did not wish to use any conventional therapy for their condition but opted to receive SNP "pad" for their condition for 3 years. The use of SNP "pad" which normalized (≈4.0 µM) the plasma NO level that in consequence reduced the death rate due to AMI, among the participants, was found to be significantly reduced compared to the death due to AMI in normal population.

Conclusion: Our data suggested that the use of SNP "pad" significantly reduced the death due to AMI.

Trial registration: www.ctri.nic.in CTRI/2013/12/004236.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flowchart representing the participation of the subjects with different cancers who received “antineoplastin” treatment.
Patients with different cancers were selected for the study and “antineoplastin” pad consisting of 0.2 ml of the solution (0.28 mmol of SNP) soaked in a band-aid was applied dermally on the lower abdominal hair-free area as described before . Please note that the whole process of delivering the “pad” containing “antineoplastin” takes less than 5 min. People from different parts of the world belonging to multi-ethnic and multi-cultural backgrounds have participated in the study including India, Poland, Papua New Guinea, Sri Lanka and Bangladesh. They had used this “antineoplastin” pad for at least a year with a maximum duration of 5 years.
Figure 2
Figure 2. Nitric oxide levels in AMI patients in South Asia and in Southern Australia.
The NO level was determined by methemoglobin method as described in the Materials and Methods section in both the cases. Panel A represents the median values of plasma NO level in AMI patients and in the equal number of age and gender matched normal volunteers in Australia. Panel B shows the median values of plasma NO level in AMI patients and in the age and gender matched normal volunteers in India.
Figure 3
Figure 3. The age group-plasma NO level adjusted regression model in both Indian and Australian AMI patients.
Regression model of the age related to the plasma NO level in both the Indian and Australian AMI patients was plotted. The age and the corresponding plasma NO level of the participants could be determined from the plot. Solid line represents the regression curve of the age group of the Indian AMI patients. Dotted line indicates the regression curve of the age group of the Australian AMI patients. Solid circles (•) indicate variations in the age group of Indian AMI patients. Solid squares (▪) indicate variations in the age group of the Australian AMI patients. The hollow circles (○) and the hollow squares (□) represent the plasma NO level in Indian and Australian patients respectively.
Figure 4
Figure 4. Kaplan-Meier model of the survival rate of the animals with ADP induced coronary thrombosis in the presence and absence of the application of dermal SNP “pad”.
To determine the survival rate in the animals from coronary thrombosis by the dermal application of SNP “pad” induced by ADP, Kaplan-Meier survival curve was plotted. Group 1 represents the animals that received the dermal application of SNP “pad”. The curve indicates the survival period which shows survival of the animals up to 72 hours after the repeated injection of ADP. Group 2 represents the control group without SNP “pad” treatment. The survival time of the animals was less than an hour as shown by the curve.

Similar articles

Cited by

References

    1. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, et al. (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1: 352–358. - PubMed
    1. Mills DC (1996) ADP receptors on platelets. Thromb Haemost 76(6): 835–56. - PubMed
    1. Fuster V, Badimon J, Chesebro JH, Fallon JT (1996) Plaque rupture, Thrombosis, and therapeutic implications. Haemostasis 26: 269–284. - PubMed
    1. Arneson H, Hoiseth A, Ly B (1982) Streptokinase or heparin in the treatment of deep vein thrombosis: follow-up results of a prospective study. Acta Med Scand 211: 65. - PubMed
    1. Belkin M, Belkin B, Bucknam CA, Straub JJ, Lowe R (1986) Intra-arterial fibrolytic therapy: Efficacy of streptokinase vs urokinase. Arch Surg 121(7): 769–73. - PubMed

Publication types